These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37947643)

  • 21. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.
    Chi H; Guan Y; Li F; Chen Z
    Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model.
    Ni W; Zhou J; Ling Y; Lu X; Niu D; Zeng Y; Qiu Y; Si Y; Wang J; Zhang W; Wang Z; Hu J
    Brain Res; 2022 Sep; 1790():147978. PubMed ID: 35690143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
    Marotta N; Kim S; Krainc D
    Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
    [No Abstract]   [Full Text] [Related]  

  • 24. PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine-induced apoptosis: Potential therapeutic strategy in Parkinson's disease.
    Bonilla-Porras AR; Arevalo-Arbelaez A; Alzate-Restrepo JF; Velez-Pardo C; Jimenez-Del-Rio M
    Cytotherapy; 2018 Jan; 20(1):45-61. PubMed ID: 29079356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver mesenchymal stem cells are superior inhibitors of NK cell functions through differences in their secretome compared to other mesenchymal stem cells.
    Yigitbilek F; Ozdogan E; Abrol N; Park WD; Hansen MJ; Dasari S; Stegall MD; Taner T
    Front Immunol; 2022; 13():952262. PubMed ID: 36211345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model.
    Khatab S; van Osch GJ; Kops N; Bastiaansen-Jenniskens YM; Bos PK; Verhaar JA; Bernsen MR; van Buul GM
    Eur Cell Mater; 2018 Nov; 36():218-230. PubMed ID: 30398288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson's Disease.
    Sun S; Zhang Q; Li M; Gao P; Huang K; Beejadhursing R; Jiang W; Lei T; Zhu M; Shu K
    Cell Transplant; 2020; 29():963689720908512. PubMed ID: 32292068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow- or adipose-mesenchymal stromal cell secretome preserves myocardial transcriptome profile and ameliorates cardiac damage following ex vivo cold storage.
    Scott SR; March KL; Wang IW; Singh K; Liu J; Turrentine M; Sen CK; Wang M
    J Mol Cell Cardiol; 2022 Mar; 164():1-12. PubMed ID: 34774548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?
    Vilaça-Faria H; Salgado AJ; Teixeira FG
    Cells; 2019 Feb; 8(2):. PubMed ID: 30717429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials.
    Ghasemi M; Roshandel E; Mohammadian M; Farhadihosseinabadi B; Akbarzadehlaleh P; Shamsasenjan K
    Stem Cell Res Ther; 2023 May; 14(1):122. PubMed ID: 37143147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells.
    Ababneh NA; Al-Kurdi B; Jamali F; Awidi A
    PeerJ; 2022; 10():e13003. PubMed ID: 35341051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc (Zn) and adipose-derived mesenchymal stem cells (AD-MSCs) on MPTP-induced Parkinson's disease model: A comparative evaluation of behavioral and immunohistochemical results.
    Yildirim S; Oylumlu E; Ozkan A; Sinen O; Bulbul M; Goksu ET; Ertosun MG; Tanriover G
    Neurotoxicology; 2023 Jul; 97():1-11. PubMed ID: 37146888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton's Jelly.
    Shin S; Lee J; Kwon Y; Park KS; Jeong JH; Choi SJ; Bang SI; Chang JW; Lee C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginkgolide A improves the pleiotropic function and reinforces the neuroprotective effects by mesenchymal stem cell-derived exosomes in 6-OHDA-induced cell model of Parkinson's disease.
    Chen WS; Lin TY; Kuo CH; Hsieh DJ; Kuo WW; Liao SC; Kao HC; Ju DT; Lin YJ; Huang CY
    Aging (Albany NY); 2023 Feb; 15(5):1358-1370. PubMed ID: 36863713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a Vimentin
    Cooper TT; Sherman SE; Bell GI; Ma J; Kuljanin M; Jose SE; Lajoie GA; Hess DA
    Stem Cells; 2020 May; 38(5):666-682. PubMed ID: 31904137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow from periacetabular osteotomies as a novel source for human mesenchymal stromal cells.
    Handke M; Rakow A; Singer D; Miebach L; Schulze F; Bekeschus S; Schoon J; Wassilew GI
    Stem Cell Res Ther; 2023 Nov; 14(1):315. PubMed ID: 37924114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
    Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
    J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of Neuropsychiatric Comorbidities in an Animal Model of Temporal Lobe Epilepsy Following Systemic Administration of Dental Pulp Stem Cells and Bone Marrow Mesenchymal Stem Cells.
    Senthilkumar S; Maiya K; Jain NK; Mata S; Mangaonkar S; Prabhu P; Rai KS; Kutty BM; Dhanushkodi A
    Curr Gene Ther; 2023; 23(3):198-214. PubMed ID: 36305152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different Sources of Mesenchymal Stem Cells for Tissue Regeneration: A Guide to Identifying the Most Favorable One in Orthopedics and Dentistry Applications.
    Costela-Ruiz VJ; Melguizo-Rodríguez L; Bellotti C; Illescas-Montes R; Stanco D; Arciola CR; Lucarelli E
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.